CHGA
Change Agents Corporation
| Capitalización | - |
|---|---|
| Volumen | - |
| Rango del día | - |
| Ingresos (TTM) | - |
| Ingreso neto | - |
| EPS | - |
| Acciones en circulación | - |
| PE | - |
| PE forward | - |
| Dividendo | - |
| Fecha ex-dividendo | - |
| Open | - |
| Close anterior | - |
| Rango 52 semanas | - |
| Beta | - |
| Analistas | - |
| Precio objetivo | - |
| Fecha de resultados | - |
Change Agents Corporation, together with its subsidiaries, develops innovative artificial intelligence platforms in the United States and China.
It operates through Consumer Health Technology and Artificial Intelligence Content Technology Segment.
The company offers automated video generation, enterprise documentation, and workflow automation solutions, as well as cellular therapy and generative AI publishing and software.
It also distributes the KetoAir device, which is a breathalyzer system that detects acetone levels in exhaled breath; and the AI Nutritionist software program that helps users monitor and manage ketogenic diet and related programs.
The company was formerly known as Avalon GloboCare Corp. and changed its name to Change Agents Corporation in July 2026.
Change Agents Corporation was founded in 2015 and is headquartered in Freehold, New Jersey.